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Cell Cycle-Regulated Phosphorylation
of p21-Activated Kinase 1
cells. Here, we used a tetracycline-regulated expression
system in an NIH-3T3-derived cell line (S2-6) [9] that
inducibly expresses HA-tagged wild-type Pak1 [10]. In
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Fox Chase Cancer Center cells arrested in mitosis with nocodazole, we noted a
distinct change in Pak1 mobility upon SDS-PAGE analy-7701 Burholme Avenue
Philadelphia, Pennsylvania 19111 sis (Figure 1C, left panel). Similar results were also ob-
tained for endogenous Pak1 in native S2-6 cells (data
not shown). The electrophoretic mobility of Pak1 was
also altered in cells arrested in mitosis with taxol (FigureSummary
1C, right panel), indicating that the altered mobility of
Pak1 is related to the cell cycle effects of nocodazoleMammalian p21-activated kinase 1 (Pak1) is a highly
conserved effector for the small GTPases Cdc42 and rather than some other mechanism.
Since such altered electrophoretic mobility is oftenRac1 [1]. In lower eukaryotes, Pak1 homologs are reg-
ulated during the cell cycle by phosphorylation. Here, due to protein phosphorylation, and because proline-
directed kinases such as Cdc2 are active at mitosis, wewe show that Pak1 is phosphorylated during mitosis
in mammalian fibroblasts. This phosphorylation oc- immunoprecipitated Pak1 from interphase and mitotic
cells and immunoblotted with an antibody directedcurs at a single site, Thr 212, within a domain that
is unique to Pak1. Cdc2 phosphorylates Pak1 at the against phospho-threonine proline ([P]-TP) motifs. Pak1
derived from nocodazole-blocked, mitotic cells, but notidentical site in vitro, and inhibition of Cdc2 abolishes
Pak1 mitotic phosphorylation in vivo, indicating that from interphase cells, strongly reacted with this anti-
body (Figure 1D). Treatment with either lambda phos-Cdc2 is the kinase responsible for phosphorylating
Pak1 in mitotic cells. Expression of a Pak1 mutant phatase or calf intestine alkaline phosphatase abolished
the altered mobility of Pak1 as well as the reactivity within which Thr 212 is replaced with a phosphomimic
(aspartic acid) has marked effects on the rate and the anti-(P)-TP antibody (Figure 1E and data not shown).
These data demonstrate that Pak1 is phosphorylatedextent of postmitotic spreading of fibroblasts. The mi-
totic phosphorylation of Pak1 does not alter the basal during the mitotic phase of the cell cycle, and that one
of the sites of phosphorylation contains a Thr-Pro motif.or Rac-stimulated activity of this kinase, but it does
affect the coimmunoprecipitation of at least three pro-
teins with Pak1. These findings are the first to implicate
Pak1 Is Phosphorylated at Thr 212 by Cdc2a mammalian Pak in cell cycle regulation and suggest
in Mitotic Cellsthat Pakl, as a result of phosphorylation by Cdc2, alters
To determine the number of mitotic phosphorylationits association with binding partners and/or substrates
sites on Pak1, we analyzed tryptic phosphopeptidethat are relevant to the morphologic changes associ-
maps of Pak1 from interphase and mitotic cells. S2-6ated with cell division.
cells expressing Pak1 were treated overnight with noco-
dazole and then metabolically labeled with 32P. Pak1Results and Discussion
was then immunoprecipitated and detected by autoradi-
ography. The Pak1 band was isolated from the gel, di-Pak1 Is Phosphorylated at Mitosis
gested with trypsin, and resolved by two-dimensionalin Murine Fibroblasts
chromatography [11] (Figure 2A, left and middle panels).Because homologs of Pak such as Ste20p and Cla4p
The phosphopeptide maps of Pak1 from mitotic cellsare known to be phosphorylated during the cell cycle
contain a single new spot compared to interphase cells,in yeast [2–5] and are known to affect cell cycle progres-
suggesting that only one new site in Pak1 is phosphory-sion in both yeast and Xenopus [6–8], we asked whether
lated. The mobility of this spot was identical to that seenPak1 is regulated in a cell cycle-dependent manner in
in phosphopeptide maps of recombinant Pak1 phos-mammalian cells. We blocked U2OS cells at the G1/S
phorylated in vitro by Cdc2 (Figure 2A, right panel).boundary using hydroxyurea, then washed out the drug
These experiments demonstrate that there is one majorand monitored Pak1 mobility on SDS-PAGE by immu-
tryptic peptide containing the site(s) of mitotic phos-noblot. Beginning at 8 hr post-wash out, a second,
phorylation on Pak1 and that this peptide is identical toslower-mobility band appeared in Pak1 immunoblots
one phosphorylated by Cdc2 in vitro.(Figure 1A). This band increased in intensity as the cells
Pak contains ten potential Cdc2 sites, as defined byapproached mitosis (Figures 1A and 1B). This experi-
serine or threonine residues followed by proline. Ofment suggests that Pak1 is modified during the G2/M
these ten sites, eight involve threonine, and only one,phase of the cell cycle.
Thr 212, matches the preferred consensus sequenceTo obtain a more uniform population of M-phase cells,
for Cdc2 (S/T-P-X-K/R) [12]. Interestingly, this site lieswe studied the mobility of Pak1 in nocodazole-arrested
within the only region of Pak1 that is not conserved
among the other two members of the mammalian group1Correspondence: j_chernoff@fccc.edu
A Pak family. To determine if Thr 212 represents an2 Present address: University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina 27599. authentic mitotic phosphorylation site on Pak1, we first
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Figure 1. Pak1 Is Phosphorylated during Mitosis
(A) U2OS cells were arrested in G1/S by adding 2 mM hydroxyurea to the media for 20 hr. The cells were then washed twice with phosphate-
buffered saline and were refed with complete media. At the indicated times, the cells were lysed and analyzed for Pak1 mobility by immunoblot
of 10% SDS-PAGE.
(B) Flow cytometric analysis of the same samples. The x axis represents DNA content, and the y axis represents cell number.
(C) S2-6 cells expressing HA-tagged Pak1 [10] were treated with 0.4 g/ml nocodazole or 0.625 M taxol for 16 hr. Mitotic cells (M) were
separated from interphase cells (I) by shake off. Protein extracts were separated by SDS-PAGE and were blotted with anti-HA sera.
(D) Pak1 from interphase and mitotic cells was immunoprecipitated using anti-HA sera, and an immunoblot was performed using an anti-
phospho-threonine proline (a-[P]-TP) antibody (Cell Signaling Technology).
(E) Pak1 from interphase and mitotic cells was immunoprecipitated as above, then treated with buffer alone or buffer containing lambda
phosphatase or calf intestine phosphatase (CIP) prior to SDS-PAGE and anti-HA immunoblot.
compared the ability of purified Cdc2 from Xenopus sible for phosphorylating Pak1 during the mitotic phase
of the cell cycle.to phosphorylate recombinant wild-type Pak1 and Pak1
T212A in vitro (Figure 2B). Wild-type Pak1 was phos-
phorylated by Cdc2, but not by inactive Cdc2 (not Sustained Phosphorylation of Pak1 at Thr 212
shown), and the phosphorylated protein was strongly Affects Postmitotic Spreading
reactive with the anti-(P)-TP antibody. The amount of To test the physiologic consequences of the phosphory-
incorporated 32P was substantially reduced when the lation of Pak1 at Thr 212, we induced the expression of
T212A mutant Pak1 was used as substrate, and all reac- wild-type Pak1, a nonphosphorylatable mutant (T212A),
tivity was lost with the anti-(P)-TP antibody. Second, we and a phosphomimic mutant (T212E) in NIH-3T3 cells
analyzed the electrophoretic mobility of wild-type and (Figure 3C) and examined the cells for cytoskeletal struc-
mutant Pak1 from mitotic cells. The Pak1 T212A mutant ture. As fibroblasts undergo a massive reorganization
failed to upshift and lost reactivity to the anti-(P)-TP of the actin cytoskeleton following cell division, and as
antibody (Figure 2C). Both of these experiments are a target of Pak1, myosin II [10], is involved in regulating
consistent with the notion that Thr 212 represents the these changes [15], we focused in particular on the ef-
major site of mitotic phosphorylation. Interestingly, the fect of Pak1 expression on the rate and extent of spread-
same site has recently been reported to be phosphory- ing in cells exiting mitotis. For these experiments, cells
lated by Cdk5 in neuronal cells [13]. were arrested in mitosis in nocodazole, and rounded
To determine if Cdc2 activity is required for phosphor- cells were detached and replated in fresh medium lack-
ylating Pak1 during mitosis, we exposed the mitotic and ing nocodazole. In the absence of Pak1 expression, cell
interphase cell extracts to selected Cdk1 inhibitors [14] morphology was not affected by any of the Pak1 con-
and examined the reactivity of immunoprecipitated Pak1 structs, and the rate and extent of postmitotic spreading
with the anti-(P)-TP antibody. As shown in Figure 2D, was identical (data not shown). However, cells express-
olomoucine significantly diminished the reactivity of mi- ing Pak1 T212E displayed an increased rate and extent
totic Pak1 with the anti-(P)-TP antibody, and alsterpaul- of postmitotic spreading relative to control cells or cells
lone completely abolished the signal. These results are expressing wild-type Pak1 or Pak1 T212A (Figures 3A
and 3B). Cells expressing Pak1 T212E spread to anconsistent with the idea that Cdc2 is the kinase respon-
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Figure 2. Pak1 Is Phosphorylated by Cdc2 at a Single New Site, Threonine 212, during Mitosis
S2-6 cells expressing HA-tagged Pak1 were grown in the presence of 0.4 g/ml nocodazole for 16 hr, grown in phosphate-free media labeled
in the presence of nocodazole for 1 hr, then metabolically labeled with 32P in the presence of nocodazole for 4 hr. Mitotic cells were shaken
off and lysed, and the remaining attached (interphase) cells were lysed on the plate. HA-tagged Pak1 was immunoprecipitated and separated
by SDS-PAGE.
(A) Phosphotryptic mapping of the in vivo-phosphorylated interphase (left panel) and mitotic (middle panel) Pak1 bands was performed
according to the method of Boyle et al. [11]. For in vitro labeling (right panel), Gst-Pak1 K299R, L404S was incubated in the presence of
Xenopus Cdc2/cyclin B plus [32P]-ATP (see the Supplementary Material available with this article online). The Cdc2/cyclin B complex was
washed away, and the phosphorylated Gst-Pak1 was eluted from the beads using SDS-PAGE sample buffer. Following SDS-PAGE, the
phosphorylated Pak1 band was excised and processed for phosphotryptic mapping.
(B) Left panel: kinase-dead Gst-Pak1 and kinase-dead Gst-Pak1 T212A were phosphorylated by Xenopus Cdc2/cyclin B [21] (see the Supple-
mentary Material). The phosphorylated proteins were separated by SDS-PAGE and were analyzed by autoradiography. The right panel shows
an immunoblot of the same proteins, using anti-(P)-TP antisera.
(C) S2-6 cells transiently expressing wild-type or Myc-tagged Pak1 T212A were arrested with nocodazole, and Pak1 mobility on SDS-PAGE
and phosphorylation status were analyzed as in Figure 1.
(D) S2-6 cells expressing wild-type Pak1 were treated with nocodazole for 16 hr, followed by vehicle or the Cdc2 inhibitors olomoucine (100
M) or alsterpaullone (10 M) for 3 hr. Interphase (I) and mitotic (M) cells were collected, and Pak1 was immunoprecipitated using anti-HA
antisera. Pak1 phosphorylation was analyzed using anti-(P)-TP sera.
average of 970 m2 by 2 hr postmitosis, compared to (lanes one and two). This “supershift” is likely to reflect
the multiple autophosphorylation sites on Pak1 that are488 and 511 m2 for WT Pak1 and Pak1 T212A, respec-
tively. These effects persisted through the remainder of stimulated upon binding activated Rac1 [19, 20]. These
results suggest that Rac-stimulated Pak1 autophos-the cell cycle (data not shown).
phorylation is not affected by the Thr 212 mitotic phos-
phorylation. Activity assays confirmed that the mitoticBiochemical Consequences
of Pak1 Phosphorylation phosphorylation of Pak1 at Thr 212 does not alter its
ability to respond to Rac1. Although the basal activitySince Pak1 phosphorylation has been associated with
the regulation of its kinase activity [16–18], we examined level of mitotic (Thr 212-phosphorylated) Pak1 is slightly
higher than interphase Pak, both forms are equally acti-the basal and GTPase-stimulated activity of Pak1 de-
rived from mitotic versus interphase cells. Extracts from vated by Rac1 (Figure 4B).
To test whether phosphorylation at Thr 212 affectsinterphase and mitotic cells expressing HA-tagged Pak1
plus or minus activated Rac1 were immunoblotted with Pak1’s ability to associate with other proteins, NIH-3T3
cells expressing wild-type or Pak1 T212A were metaboli-12CA5 and anti-(P)-TP antibodies. As noted previously,
the electrophoretic mobility of Pak1 was retarded in cally radiolabeled with 35S, and HA-tagged Pak1 was
immunoprecipitated from mitotic and interphase cellsmitotic cells (Figure 4A, compare lanes three and four).
Coexpression of activated Rac1 resulted in an identical (Figure 4C). As expected, wild-type, but not Pak1 T212A,
upshifted in mitotic cells (compare70 kDa Pak1 bands“supershift” of Pak1 in both interphase and mitotic cells
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Figure 3. Sustained Phosphorylation of Pak1 at Thr 212 Affects Postmitotic Spreading
(A) S2-6 cells expressing HA-tagged wild-type (WT), Pak1 T212A, or Pak1 T212E were grown for 24 hr in the absence of tetracycline and were
synchronized in M phase using nocodazole for 4 hr, and mitotic cells were shaken off, washed, and replated in growth media. At the indicated
times, cells were fixed and stained for F-actin using Oregon green-phalloidin. Cells are shown at 20 magnification. The scale bar represents
20 m.
(B) The relative areas of individual cells from Metamorph images were quantified with the use of National Institutes of Health Image software.
Data from these experiments were considered significantly different if the p values, as determined by two-tailed t tests, were 0.05. The y
axis shows area in m2 .
(C) Anti-HA blot.
in lanes 2 and 4). In interphase cells expressing either about 93, 45, and 35 kDa coprecipitated with unphos-
phorylated Pak1 (i.e., Pak1 T212A), but this binding waswild-type or Pak1 T212A, four prominent proteins copre-
reduced more than 90% to the wild-type protein that iscipitated with Pak1, and the pattern of these coprecipi-
phosphorylated at Thr 212 (compare lanes 2 and 4).tating proteins was identical (compare lanes 1 and 3).
Interestingly, the relative abundance of the 45-kDa Pak1However, in mitotic cells, in which wild-type Pak1 is
binding protein was increased at mitosis. These resultsphosphorylated but the T212A mutant is not, the binding
indicate that the phosphorylation of Pak1 at Thr 212patterns were markedly different. Immunoprecipitates
impedes its ability to associate with at least three pro-of wild-type Pak1 from mitotic cells consistently gave
teins during mitosis. As the T212 phosphorylation sitea “cleaner” appearance on autoradiography, indicating
lies within a proline-rich motif (PLPVTPTR), it is possiblethat the binding of multiple Pak1 partners might be dis-
that one or more of these unknown proteins contain anrupted by phosphorylation. The binding of two known
SH3 domain.Pak-interacting proteins, Nck and PIX, were not altered
in mitotic cells (data not shown). In Pak1 T212A immuno-
Supplementary Material
precipitates from mitotic cells, the differential associa- Supplementary Material including procedures for metabolic labeling
tion of three proteins was especially apparent (Figure and protein kinase assays is available at http://images.cellpress.
com/supmat/supmatin.htm.4C, arrows). In mitotic extracts, proteins migrating at
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Figure 4. Mitotic Phosphorylation of Pak1 at Thr 212 Alters Protein-Protein Interactions, but Not Protein Kinase Activity
(A) S2-6 cells expressing Pak1 were treated for 16 hr with nocodazole, and interphase (I) and mitotic (M) cells were collected. Pak1 was
immunoprecipitated with anti-Pak1 sera and treated with buffer alone or GTP-Rac1. The proteins were analyzed by immunoblot with anti-HA
and anti-(P)-TP sera.
(B) Pak1 was immunoprecipitated from mitotic and interphase cells as in (A). Kinase activity was determined using histone 4 (H4) as a substrate.
An autoradiogram is shown (bottom).
(C) S2-6 cell lines expressing wild-type or Pak1 T212A were grown for 16 hr in medium containing nocodazole. The cells were metabolically
labeled with [35S]methionine and cysteine (see the Supplementary Material), and HA-tagged Pak1 was immunoprecipitated from mitotic and
interphase cells. Bound proteins were eluted with SDS-PAGE sample buffer and chromatographed by SDS-PAGE. An autoradiogram is shown.
Signal intensities were measured by densitometry. Molecular weight standards are indicated at the left.
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